Commonly prescribed asthma drug, Singulair, linked to mental side effects

Commonly prescribed asthma drug, Singulair, linked to mental side effects

The Food and Drug Administration (FDA) issued a warning to a commonly prescribed asthma medication in 2020 — but millions are still taking it. A black box warning, also called a boxed warning, was issued by the FDA in March 2020 about the mental health side effects of Singulair, also known by its generic name, … Read more